SJ

Saloni Jha

Active Director Director DIN 09785610
DIN 09785610 First appointment Nov 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Saloni Jha

Data last updated:

Saloni Jha is a Director at Welsave Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Welsave Pharmaceuticals Private Limited reported revenue of ₹7.1 Lakh (FY 2025).

DIN 09785610
Primary Designation Director
Industry Chemicals
First Appointment 09 Nov 2022
Oldest Company Age 4 yrs
Largest company Welsave Pharmaceuticals Private Limited · ₹7.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Nov 20222022₹7.1 Lakh (FY 2025)Active

Board colleagues of Saloni Jha

NameDINCompanyDesignation
Rahul Khemka06968240Welsave Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Welsave Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Saloni Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saloni Jha

Saloni Jha currently holds 1 directorship: Welsave Pharmaceuticals Private Limited (Director, since 09 Nov 2022, revenue ₹7.1 Lakh (FY 2025)).

Saloni Jha was first appointed on 09 Nov 2022 as Director at Welsave Pharmaceuticals Private Limited.

The current boards of Saloni Jha's companies include Rahul Khemka (Welsave Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available